Aptitude Metrix COVID Test Receives FDA 510(k) Clearance
Carlsbad, California, USA, September 17, 2026 Aptitude Medical Systems has announced that the U.S. Food and Drug Administration (FDA)...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Carlsbad, California, USA, September 17, 2026 Aptitude Medical Systems has announced that the U.S. Food and Drug Administration (FDA)...
Sunnyvale, California, U.S., September 8, 2026 Anitoa Systems, LLC has announced the integration of secure cloud connectivity and enterprise-grade...
Irving, Texas, USA, August 7, 2026 Caris Life Sciences has announced the publication of a new study demonstrating that...
Salt Lake City, Utah, USA, August 7, 2026 Co-Diagnostics, Inc. has reached a major regulatory milestone by submitting a...
SAN JOSE, California, July 2, 2026 Visby Medical has received U.S. Food and Drug Administration (FDA) clearance for the...
HALIFAX, NOVA SCOTIA | December 30, 2025 — MedMira Inc. reported its first-quarter FY2026 results, highlighting a pivotal period...
SALT LAKE CITY, December 29, 2025 — Co-Diagnostics announced that the Australian Patent Office has granted a key patent...
